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Questions: Does constraint-induced movement therapy improve activity and participation in children
with hemiplegic cerebral palsy? Does it improve activity and participation more than the same dose of
upper limb therapy without restraint? Is the effect of constraint-induced movement therapy related to
the duration of intervention or the age of the children? Design: Systematic review of randomised trials
with meta-analysis. Participants: Children with hemiplegic cerebral palsy with any level of motor
disability. Intervention: The experimental group received constraint-induced movement therapy
(deﬁned as restraint of the less affected upper limb during supervised activity practice of the more
affected upper limb). The control group received no intervention, sham intervention, or the same dose of
upper limb therapy. Outcomemeasures:Measures of upper limb activity and participation were used in
the analysis. Results: Constraint-induced movement therapy was more effective than no/sham
intervention in terms of upper limb activity (SMD 0.63, 95% CI 0.20 to 1.06) and participation (SMD 1.21,
95% CI 0.41 to 2.02). However, constraint-induced movement therapy was no better than the same dose
of upper limb therapy without restraint either in terms of upper limb activity (SMD 0.05, 95% CI –0.21 to
0.32) or participation (SMD –0.02, 95% CI –0.34 to 0.31). The effect of constraint-induced movement
therapy was not related to the duration of intervention or the age of the children. Conclusions: This
review suggests that constraint-induced movement therapy is more effective than no intervention, but
no more effective than the same dose of upper limb practice without restraint. Registration: PROSPERO
CRD42015024665. [Chiu H-C, Ada L (2016) Constraint-induced movement therapy improves upper
limb activity and participation in hemiplegic cerebral palsy: a systematic review. Journal of
Physiotherapy 62: 130–137]
 2016 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Cerebral palsy is a non-progressive neurological condition
resulting in motor impairments that can change over time.1 The
impairments may originate directly from damage to an immature
brain, or indirectly from compensatorymovements or disuse during
development.1 Such impairments may result in activity limitations
that require rehabilitation throughout life.1 Among children with
cerebral palsy, 29% have hemiplegia, that is, one side of the body is
affected much more than the other, and the upper limb is typically
more involved than the lower limb.2 They may develop ‘learned
non-use’ in their affected upper limb, because they tend to learn
alternative strategies to manage daily tasks using the less affected
limb.3–5 Performance of tasks is often more efﬁcient using the less
affected upper limb, even if there is only mild impairment in the
more affected limb.3 Children with hemiplegic cerebral palsy
usually have the intellectual capacity to attend regular schools, yet
impaired upper limb function tends to restrict their participation in
education and leisure, and impact their social image.
Therapists working with children with hemiplegic cerebral
palsy encourage movement of the affected limb by repetitive
practice of unilateral and bimanual activities. Constraint-induced
movement therapy (CIMT) aims to overcome ‘learned non-use’ byhttp://dx.doi.org/10.1016/j.jphys.2016.05.013
1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).intensive, targeted practice with the more affected limb during
restraint of the less affected limb.5 While restrained, only the
affected upper limb can be used to carry out activities, forcing
children to ﬁnd solutions to their movement problems.4,5
There are four systematic reviews speciﬁcally examining the
effect of CIMT in children with cerebral palsy or hemiplegia from
other causes.5–8 Two of the reviews included all published studies,
regardless of design, and included low levels of evidence such as
case studies.5,8 The Cochrane review on this topic has not been
updated since 2007 and includes only three randomised trials.
These three trials were not pooled into a meta-analysis but the
authors concluded that there was a trend towards a beneﬁcial
effect of CIMT.7 Themost recent review6 to focus on CIMT reported
a standardised effect size of 0.55 from the pooled estimate of
27 randomised trials of CIMT versus conventional therapy. One of
the post-hoc analyses carried out was to divide the trials on the
basis of the equivalence of dose of intervention. When CIMT was
compared with a dose-equivalent intervention, the effect was
much smaller (SMD 0.37) than the effect among trials without a
dose-equivalent comparison group (SMD 0.84). These results give
insight into themechanism of CIMT. The effect of CIMTmay be due
to nothingmore than the large amounts of practice that restraint of
the less affected upper limb produces..V. This is an open access article under the CC BY-NC-ND license (http://
Research 131In order to fully investigate the effect of CIMT on children with
hemiplegic cerebral palsy, trials where CIMT is compared with no
intervention need to be pooled separately from trials where CIMT
is comparedwith the same dose of practicewithout restraint of the
unaffected limb. The present systematic review therefore took this
approach. In addition, this review examined outcomes at the level
of activity and participation, because not only is the effect of CIMT
on upper limb activity of interest, but also how improved activity
might translate into the broader context of using the upper limb to
participate at home, at school and in the community. This review
also sought to determine whether the amount of beneﬁt obtained
from CIMT is associated with certain characteristics of the children
or the CIMT.
Therefore, the research questions for this systematic review
were:1. Does CIMT improve activity and participation in children with
hemiplegic cerebral palsy?2. Does CIMT improve activity and participation more than the
same dose of upper limb therapy without restraint?3. Is the effect of CIMT related to the duration of intervention or the
age of the child?
Method
Identiﬁcation and selection of studies
Searches were conducted of Medline (1966 to June 2015),
CINAHL (1982 to June 2015), PubMed (1966 to June 2015), Embase
(1974 to June 2015), the Cochrane Library (1966 to June 2015),
Web of Science (1945 to June 2015) and the Physiotherapy
Evidence Database (PEDro) (to June 2015), without language
restrictions using words related to cerebral palsy and randomised
controlled trials and words related to constraint-induced movement
therapy (such as constraint-induced movement therapy, forced
and massed practice) (see Appendix 1 for full search strategy).
Titles and abstracts were displayed and screened by one reviewer
to identify relevant studies. Full-text copies of relevant studies
were retrieved and their reference lists were screened. The
methods of the retrieved papers were screened independently
by two reviewers against the inclusion criteria: randomised or
quasi-randomised trials; children or adolescents (< 18 years of
age) with hemiplegic cerebral palsy; experimental intervention of
CIMT; control intervention of no/sham intervention or same dose
of upper limb therapy; and outcome measure(s) of activity or
participation (Box 1).Box 1. Inclusion criteria.
Design
 randomised or quasi-randomised trial
Participants
 children (ie, < 18 years old)
 hemiplegic cerebral palsy
 any level of disability
Intervention
 constraint-induced movement therapy (ie, restraint of the
less affected limb) applied during supervised activity
practice of the more affected upper limb
Outcome measures
 measures of activity or participation
Comparisons
 constraint-induced movement therapy vs no/sham
intervention (sham defined as usual therapy  20% of
time restrained)
 constraint-induced movement therapy vs same dose of
upper limb therapy (defined as  time restrained)Assessment of characteristics of studies
Quality
The quality of included studies was assessed by extracting
PEDro scores from the PEDro website. Each score on the PEDro
website is generated by two accredited raters scoring the trial, with
any discrepancies in rating resolved by a third accredited rater.
Participants
Studies involving participants of either gender, regardless of the
level of initial disability, were included. The Manual Ability
Classiﬁcation System was used to quantify the severity of upper
limb disability. The Manual Ability Classiﬁcation System classiﬁes
how children with cerebral palsy use their hands to handle objects
in daily activities, with I = minor limitations and V = severe
limitations.9 Age and Manual Ability Classiﬁcation System level
were recorded so that the similarity of participants between
studies could be examined. If the Manual Ability Classiﬁcation
System level was not reported, reviewers classiﬁed the partici-
pants based on the available information.
Intervention
The experimental group had to have received CIMT (deﬁned as
restraint of the less affected upper limb during task practice of the
more affected upper limb). To be eligible to answer the ﬁrst study
question, the control group had to receive no/sham intervention,
deﬁned as usual therapy  20% of the time that the experimental
group spent restrained. To be eligible to answer the second study
question, the control group received the same dose of upper limb
therapy (unilateral or bilateral or both), deﬁned as equal to or
greater than the time that the experimental group spent
restrained. Participants could be receiving other therapy as long
as both groups received it. The frequency and duration of the
intervention was recorded so that the similarity of intervention
between studies could be examined.
Outcome measures
Measures that reﬂected upper limb activity and participation
were used in the analysis. Upper limb activity was measured as
what the child could do with their more affected limb. Therefore,
measures using direct observation of unimanual performance of
standardised upper limb tasks, such as Jebsen-Taylor Test of Hand
Function, Nine-Hole Peg Test or Bruininks-Oseretsky Test of Motor
Proﬁciency, Quality of Upper Extremity Skills Test or Melbourne
Assessment of Unilateral Upper Limb Function, were used and
reported as either level of difﬁculty or time taken. Upper limb
participation was measured as what the child did in real life.
Therefore, measures using direct observation or parent perception
of bimanual real-life play, such as the Assisting Hand Assessment
or Pediatric Motor Activity Log, were used and reported as level of
difﬁculty.
Data analysis
Data were extracted from the included studies by one reviewer
and cross-checked by a second reviewer. Information about the
method (ie, design, participants, intervention and measures) and
outcome data (ie, number of participants, mean (SD) activity and
participation) were extracted. Authors of papers with missing data
were contacted.
Most studies reported post-intervention scores immediately
after intervention; therefore, these scores were used to obtain the
pooled estimate of the effect of intervention. Since different
measurement tools were used, the effect size was reported as
Cohen’s standardised mean difference (SMD, 95% CI). A random-
effects model was used. The analyses were performed using MIX
2.0, which is a statistical add-in for performing meta-analysis in
Excel.10,11
Simple linear regression was used to determine the association
between the duration of CIMT and the effect of CIMT (on activity
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Figure 1. Flow of studies through the review.
RCT = randomised controlled trial, CIMT = constraint-induced movement therapy,
mCIMT = modiﬁed constraint-induced movement therapy.
Chiu and Ada: Constraint-induced movement in cerebral palsy32and participation) and as well as between age and the effect of
CIMT (on activity and participation). Only the no/sham treatment-
controlled studies were used in this analysis.
Results
Flow of studies through the review
The search strategy identiﬁed 597 studies. After screening
titles and abstracts, 46 full papers were retrieved. After being
assessed against the inclusion criteria, 31 papers12–42 of 21
studies12,14–18,21–24,27,28,30,31,36–42 were included in the review
(Figure 1; see Appendix 2 for excluded papers).
Characteristics of included studies
The 21 studies provided 22 comparisons that were relevant to
this review because one study had three arms (reported in
Fedrizzi et al 201324 and Facchin et al 201125). Among
the 22 comparisons, 15 investigated CIMT versus no/sham
intervention12,15–18,22–24,30,36–40,42 and seven investigated CIMT
versus the same dose of upper limb therapy.14,21,24,27,28,31,41
A summary of the studies is presented in Table 1.
Quality
The mean PEDro score of the papers was 5.8 (range 3 to 8)
(Table 2). The majority of the papers: were randomised (100%),
analysed the between-group difference (97%), reported point
estimates and variability (87%), had similar groups at baseline
(84%), reported < 15% loss to follow-up (74%) and had blinded
assessors (65%). The majority of studies did not conceal the
allocation list (58%), carry out an intention-to-treat analysis (65%),
nor blind participants or therapists (100%).
Participants
Participants were children and adolescents who were classiﬁed
as having hemiplegic cerebral palsy, with the mean age across
studies ranging from 2.4 to 10.2 years. Fourteen studies (63%)
involved participants aged < 4 years. Most of the studiesinvestigated children classiﬁed as Manual Ability Classiﬁcation
System level I/II/III in the more affected limb (ie, able to handle
objects without or with adaptive behaviour).
Intervention
The experimental group received CIMT with supervised
upper limb practice (22 comparisons). The types of restraint
included slings (seven studies), splints (four studies), gloves
(eight studies), casts (two studies), and bandage (one study).
Restraint was worn for 35 hours/week (range 2 to 84) for a
duration of 5 weeks (range 2 to 10) in the comparisons with no/
sham intervention and 23 hours/week (range 12 to 30) for a
duration of 5 weeks (range 2 to 10) in the comparisons with the
same dose of upper limb therapy. Supervised practice was
undertaken for 50% of the time that the restraint was worn in
the comparisons with no/sham intervention and 100% of the
time that restraint was worn in the comparisons with the same
dose of upper limb therapy. The control group received no/sham
intervention (15 comparisons) or the same dose of upper limb
therapy (seven comparisons). Sham intervention was a small
amount (range 0.3 to 2.2 hours/week) of usual therapy, which
was not necessarily speciﬁc to the upper limb and often not
speciﬁed. The same dose of upper limb therapy usually involved
bilateral training. Both groups received usual therapy in six
comparisons.
Outcome measures
Measures of upper limb activity were reported in 19 studies.
The measures chosen for the analysis of upper limb activity were:
Jebsen-Taylor Test of Hand Function (four studies), Bruininks-
Oseretsky Test of Motor Proﬁciency (one study), Quality of Upper
Extremity Skills Test (six studies), Nine-Hole Peg Test (one study),
Melbourne Assessment of Unilateral Upper Limb Function (three
studies), Box and Block Test (two studies) and Pediatric Arm
Function Test (two studies).
Measures of upper limb participation were reported in
12 studies. The measures chosen for the analysis of upper limb
participation were: Assisting Hand Assessment (eight studies),
Pediatric Motor Activity Log (three studies) and Caregiver
Functional Use Survey (one study).
Effect of constraint-induced movement therapy versus no/sham
intervention
Activity
The immediate effect of CIMT compared with no/sham
intervention on activity was examined by pooling post-interven-
tion data from 11 comparisons with a PEDro score of 5.5 and
302 participants, using a random-effects model. Four studies were
unable to be included in the analysis because they had no
appropriate measure of activity13,22,40 or because of missing
data.38 CIMT increased activity (SMD 0.63, 95% CI 0.20 to 1.06)
compared with no/sham intervention (Figure 2). See Figure 3 on
the eAddenda for the detailed forest plot. There was substantial
statistical heterogeneity (I2 = 65%), indicating that the variation
between the results of the trials was above the variation expected
by chance. Sensitivity analyses revealed that the heterogeneity
was not explained by the quality of the trials, assessor blinding,
number or severity of participants.
Participation
The immediate effect of CIMT compared with no/sham
intervention on participation was examined by pooling post-
intervention data from eight comparisons with a PEDro score of
5.5 and 215 participants, using a random-effects model. Seven
studies were unable to be included in the analysis because they
had no appropriate measure of participation.17,18,23,24,36,37,42
CIMT increased participation (SMD 1.21, 95% CI 0.41 to 2.02)
compared with no/sham intervention (Figure 4). See Figure 5
on the eAddenda for the detailed forest plot. There was
Table 1
Characteristics of included studies (n=21 studies across 31 papers, with 22 comparisons).
Study Design Participants Intervention Outcome measures
Experimental Control Both
CIMT versus no/sham intervention
Aarts et al 201012
Aarts et al 201113
Geerdink
et al 201326
RCT n=50
Mean age (range) =2.9 yr
(2.5 to 8)
Classiﬁcation=hemiplegia,
MACS I to III
Restraint = sling
3 h/d x 3/wk x 6 wk
(Total: 54 h)
Super=3 h/d x 3/wk
x 6 wk+ Bimanual
practice
3 h/d x 3/wk x 2 wk
(Total: 72 h)
Usual therapy
1.5 h/wk x 8 wk
(Total: 12 h)
 Activity: MAUULF
(0 to 100)
 Participation: AHA
(0 to 100)
 Timing=0, 9, 26, 52 wk
Al-Oraibi
et al 201115
RCT n=14
Mean age (range) =4.8 yr
(1.8 to 9)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint = glove
2 h/d x 6 or 7/wk x
8 wk (Total: 92 h)
Super=2 h/d x 6/wk
x 8 wk (Total: 92 h)
Usual therapy
2 h/wk x 8 wk
(Total: 16 h)
 Participation: AHA
(0 to 100)
 Timing=0, 8 wk
Charles
et al 200616
RCT n=22
Mean age (range) =6.7 yr
(4 to 8)
Classiﬁcation= spastic
hemiplegia, MACSa I to III
Restraint = sling
6 h/d x 5/wk x 2 wk
(Total: 60 h)
Super=7 h/d x 5/wk
x 2 wk (Total: 70 h)
No intervention  Activity: JTTHFb (s)
 Participation: CFUS-freq
(0 to 5)
 Timing=0, 3 wk
Choudhary
et al 201317
RCT n=31
Mean age (range) =5.1 yr
(3 to 8)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = sling
3 h/d x 2-3/wk x
4 wk + 2 h/d x 4-5/
wk x 4 wk (Total:
66 h)
Super=2 h/d x 2-3/
wk x 4 wk (Total:
20 h)
No intervention Usual therapy
0.3 h/d x 7/
wk x 4 wk
(Total: 8.5 h)
 Activity: QUEST-grasp
(0 to 100)
 Timing=0, 4, 12 wk
De Brito Branda˜o
et al 201018
RCT n=16
Mean age (range) =6 yr
(4 to 8)
Classiﬁcation= spastic
hemiplegia, MACS I to III
Restraint = sling
10 h/d x 5/wk x 2 wk
(Total =100 h)
Super=3 h/d x 5/wk
x 2 wk+ bimanual
practice
0.75 h/d x 3/wk x
1 wk (Total: 32 h)
Usual therapy
0.75 h/wk x 3 wk
(Total =2 h)
 Activity: JTTHFb (s)
 Timing=–1, 3, 7 wk
Eliasson et al 201122 Cross-over
RCT
n=25
Mean age (range) =2.4 yr
(1.5 to 5)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint = glove
2 h/d x 7/wk x 8 wk
(Total: 102 h)
Super=2 h/d x 7/wk
x 8 wk (Total: 102 h)
No intervention Usual therapy  Participation: AHA
(0 to 100)
 Timing=0, 8 wk
Eugster-Buesch
et al 201223
RCT n=23
Mean age (range) =10.7 yr
(6 to 16)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = splint
6 h/d x 7/wk x 2 wk
(Total: 84 h)
Super=2 h/d x 7/wk
x 2 wk (Total: 28 h)
No intervention Usual therapy  Activity: MAUULF
(0 to 100)
 Timing=0, 2, 12, 52 wk
Fedrizzi
et al 201324
Facchin
et al 201125
RCT n=48
Mean age (range) =4.3 yr
(2 to 8)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint = glove
3 h/d x 7/wk x 10 wk
(Total: 210 h)
Super=3 h/d x 7/wk
x 10 wk (Total:
210 h)
Usual therapy
1-2/wk x 10 wk
(Total: 15 h)
 Activity: QUEST-grasp (%)
 Timing=0, 10, 12, 26 wk
Rostami
et al 201230
RCT n=16
Mean age (range) =8.2 yr
(6 to 12)
Classiﬁcation= spastic
hemiplegia, MACSa I to III
Restraint=splint
5 h/d x 7/wk x 4wk
(Total: 140 h)
Super=1.5 h/d x 3/wk
x 4 wk (Total: 18 h)
No intervention Usual therapy
0.5 h/d x 2/
wk x 4 wk
(Total: 4 h)
 Activity: BOTMP-subtest
8 (0 to 9)
 Participation: PMAL-quality
(0 to 5)
 Timing=0, 4, 12 wk
Smania
et al 200936
Cross-over
RCT
n=10
Mean age (range) =3.3 yr
(1 to 9)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = glove
8 h/d x 7/wk x 5 wk
(Total: 280 h)
Super=1 h/d x 2/wk
x 5 wk (Total: 10 h)
Usual therapy
1 h/d x 2/wk x 5 wk
(Total: 10 h)
 Activity: PAFT (0 to 120)
 Timing=0, 5 wk
Sung et al 200537 RCT n=31
Mean age (range) =3.1 yr
( 8)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = cast
12 h/d x 7/wk x 6 wk
(Total: 500 h)
Super=0.5 h/d x 2/
wk x 6 wk (Total:
6 h)
Usual therapy
0.5 h/d x 2/wk x 6 wk
(Total: 6 h)
 Activity: BBT (blocks)
 Timing=0, 6 wk
Taub
et al 200438
DeLuca
et al 200620
RCT n=18
Mean age (range) =3.5 yr
(0.5 to 8)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint = cast
12 h/d x 7/wk x 3 wk
(Total: 250 h)
Super=6 h/d x 7/wk
x 3 wk (Total: 125 h)
Usual therapy
2.2 h/wk x 3 wk
(Total =7 h)
 Activity: QUEST (%)
 Participation: PMAL-quality
(0 to 5)
 Timing=0, 3 wk
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Study Design Participants Intervention Outcome measures
Experimental Control Both
Taub et al 201139 RCT n=20
Mean age (range) =3.7 yr
(2 to 6)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint = splint
12 h/d x 5/wk x 3 wk
(Total: 90 h)
Super =6 h/d x 5/wk
x 3 wk (Total: 90 h)
No intervention Usual therapy
1.5 hr/wk x 3 wk
(Total: 4.5 h)
 Activity: PAFT (0 to 64)
 Participation: PMAL-quality
(0 to 5)
 Timing =0, 3 wk
Wallen
et al 201140
RCT n=50
Mean age (range) =3.1 yr
(1.5 to 8)
Classiﬁcation= spastic
hemiplegia, MACS I to IV
Restraint =glove
2 h/d x 7/wk x 8 wk
(Total: 112 h)
Super =2 h/d x 7/wk
x 8 wk (Total: 112 h)
Usual therapy
0.3 h x 7/wk x 8 wk
(Total: 17 h)
 Participation: AHA
(0 to 100)
 Timing =0, 10, 26 wk
Yu et al 201242 RCT n=20
Mean age
(range) =9.4 yr
(9 to 10)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = sling
1 h/d x 2/wk x 10 wk
(Total: 20 h)
Super =1 h/d x 2/wk
x 10 wk (Total: 20 h)
No intervention Usual therapy
0.5 h/d x 2/wk
x 10 wk
(Total: 10 h)
 Activity: BBT (blocks)
 Timing =0, 10 wk
CIMT versus same dose of upper limb therapy
Abd el-Kafy
et al 201414
RCT n=27
Mean age (range) =6.1 yr
(4 to 8)
Classiﬁcation= spastic
hemiplegia, MACS II to IV
Restraint = sling
6 h/d x 5/wk x 4 wk
(Total: 120 h)
Super =6 h/d x 5/wk
x 4 wk (Total: 120 h)
Bimanual practice
6 h/d x 5/wk x 4 wk
(Total: 120 h)
 Activity: QUEST (%)
 Timing =0, 4, 12 wk
Deppe
et al 201321
RCT n=29
Mean age (range) =6.3 yr
(3.3 to 12)
Classiﬁcation=hemiplegia,
MACS I to III
Restraint =bandage
4 h/d x 5/wk x 3 wk
(Total: 60 h)
Super =4 h/d x 5/wk
x 3 wk
+ bimanual practice
4 h/d x 5/wk x 1 wk
(Total: 80 h)
Bimanual practice
4 h/d x 5/wk x 4 wk
(Total: 80 h)
 Activity: MAUULF (0 to 122)
 Participation: AHA (22 to 88)
 Timing =0, 4 wk
Fedrizzi
et al 201324
Facchin
et al 201125
RCT n=48
Mean age (range) =4 yr
(2 to 8)
Classiﬁcation=hemiplegia,
MACSa I to V
Restraint =glove
3 h/d x 7/wk x 10 wk
(Total: 210 h)
Super =3 h/d x 3/wk
x 10 wk (Total:
210 h)
Bimanual practice
3 h/d x 7/wk x 10 wk
(Total: 210 h)
 Activity: QUEST-grasp (%)
 Timing =0, 10, 26 wk
Gelkop et al 201527 Cross-over
RCT
n=12
Mean age (range) =4.3 yr
(1.5 to 7)
Classiﬁcation= spastic
hemiplegia, MACS I to III
Restraint =glove
2 h/d x 6/wk x 8 wk
(Total: 96 h)
Super =2 h/d x 6/wk
x 8 wk (Total: 96 h)
Bimanual practice
2 hx 6/wk x 8 wk
(Total: 96 h)
 Activity: QUEST-grasp (%)
 Participation: AHA
(0 to 100)
 Timing =0, 8 wk
Gordon
et al 201128
De Brito Brandao
et al 201219
Hung et al 201129
RCT n=42
Mean age (range) =6.3 yr
(3.5 to 10)
Classiﬁcation=hemiplegia,
MACS I to III
Restraint = sling
6 h/d x 5/wk x 3 wk
(Total: 90 h)
Super =6 h/d x 5/wk
x 3 wk (Total: 90 h)
Bimanual practice
6 h/d x 5/wk x 3 wk
(Total: 90 h)
 Activity: JTTHFb (s)
 Participation: AHA (logits)
 Timing =0, 3 wk
Sakzewski
et al 2011a31
Sakzewski
et al 2011b32
Sakzewski
et al 2011c33
Sakzewski
et al 2011d34
Sakzewski
et al 201235
RCT n=63
Mean age (range) =10.2 yr
(5 to 16)
Classiﬁcation= spastic
hemiplegia, MACS I to III
Restraint =glove
6 h/d x 5/wk x 2 wk
(Total: 60 h)
Super =6 h/d 5/wk x
2 wk (Total: 60 h)
Bimanual practice
6 h/d x 10 days
(Total: 60 h)
 Activity: JTTHFb (s)
 Participation: AHA
(0 to 100)
 Timing =0, 3 wk
Xu et al 201241 RCT n=45
Mean age (range) =4.6 yr
(2 to 14)
Classiﬁcation=hemiplegia,
MACSa I to III
Restraint = splint
3 h/d x 5/wk x 2 wk
(Total: 30 h)
Super =4 h/d x 5/wk
x 2 wk (Total: 40 h)
Bimanual practice
3 h/d x 5/wk x 2 wk
(Total: 30 h)
 Activity: 9-HPTb (s)
 Timing =0, 2 wk
a MACS level estimated by reviewers.
b Experimental and control scores reversed for analysis because a smaller score denotes better performance.
AHA=Assisting Hand Assessment, BBT=Box and Block Test, BOTMP=Bruininks-Oseretsky Test of Motor Proﬁciency, CFUS freq=Caregiver Functional Use Survey,
JTFHT= Jebsen-Taylor Test of Hand Function, MACS=Manual Ability Classiﬁcation System, MAUULF=Melbourne Assessment of Unilateral Upper Limb Function,
PAFT=Pediatric Arm Function Test, PMAL=Pediatric Motor Activity Log, QUEST=Quality of Upper Extremity Skills Test, RCT= randomised controlled trial, Super = supervised
practice, 9-HPT=Nine Hole Peg Test.
Chiu and Ada: Constraint-induced movement in cerebral palsy134substantial statistical heterogeneity (I2 = 84%), indicating that
the variation between the results of the trials was above the
variation expected by chance. Sensitivity analyses revealed
that the heterogeneity was not explained by the quality of
the trials, assessor blinding or the number or severity
of participants.Effect of constraint-inducedmovement therapy versus same dose
of upper limb therapy
Activity
The immediate effect of CIMT compared with the same dose of
upper limb therapy on activity was examined by pooling data after
Table 2
PEDro scores for included papers (n=31).
Study Random
allocation
Concealed
allocation
Groups
similar at
baseline
Participant
blinding
Therapist
blinding
Assessor
blinding
< 15%
dropouts
Intention-
to-treat
analysis
Between-group
difference
reported
Point
estimate and
variability
reported
Total
(0 to 10)
Aarts et al 201012 Y N Y N N Y Y N Y Y 6
Aarts et al 201113 Y N Y N N Y Y N Y Y 6
Abd el-Kafy et al 201414 Y N Y N N Y Y N Y N 5
Al-Oraibi et al 201115 Y N N N N Y N N Y Y 4
Charles et al 200616 Y N Y N N Y N N Y Y 5
Choudhary et al 201317 Y Y Y N N Y Y Y Y Y 8
De Brito Branda˜o et al 201018 Y Y Y N N Y Y Y Y Y 8
De Brito Branda˜o et al 201219 Y Y Y N N N Y N Y Y 6
De Luca et al 200620 Y N N N N Y Y N Y N 4
Deppe et al 201321 Y Y Y N N Y Y N Y Y 7
Eliasson et al 201122 Y N N N N Y N N Y Y 4
Eugster-Buesch et al 201223 Y Y Y N N Y Y N Y Y 7
Fedrizzi et al 201324 Y N Y N N N Y N Y N 4
Facchin et al 201125 Y N Y N N N Y N Y N 4
Geerdink et al 201326 Y N Y N N N Y Y Y Y 6
Gelkop et al 201527 Y Y Y N N Y Y Y Y Y 8
Gordon et al 201128 Y Y Y N N Y Y N Y Y 7
Hung et al 201129 Y N N N N Y Y N Y Y 5
Rostami et al 201230 Y N Y N N Y Y Y Y Y 7
Sakzewski et al 2011a31 Y Y Y N N N Y Y Y Y 7
Sakzewski et al 2011b32 Y Y Y N N Y Y Y Y Y 8
Sakzewski et al 2011c33 Y Y Y N N N Y Y Y Y 7
Sakzewski et al 2011d34 Y Y Y N N N Y Y Y Y 7
Sakzewski et al 201235 Y Y Y N N N Y Y Y Y 7
Smania et al 200936 Y N N N N Y N N Y Y 4
Sung et al 200537 Y N Y N N N N N Y Y 4
Taub et al 200438 Y N Y N N Y N N Y Y 5
Taub et al 201139 Y N Y N N N Y N Y Y 5
Wallen et al 201140 Y Y Y N N Y Y Y Y Y 8
Xu et al 201241 Y N Y N N Y N N Y Y 5
Yu et al 201242 Y N Y N N N N N N Y 3
Y=yes, N=no, PEDro=Physiotherapy Evidence Database.
PEDro scores extracted from website www.pedro.org.au
Research 135intervention from ﬁve comparisons with a PEDro score of 6.8 and
218 participants, using a random-effects model. Two studies were
unable to be included in the analysis because they had no post-
intervention data41 or missing data.14 CIMT did not increase
activity (SMD 0.05, 95% CI –0.21 to 0.32, I2 = 0%) comparedwith the
same dose of upper limb therapy (Figure 6). See Figure 7 on the
eAddenda for the detailed forest plot.
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Figure 2. SMD (95% CI) of effect of constraint-inducedmovement therapy compared
with no/sham intervention on upper limb activity immediately after intervention
by pooling data from 11 trials (n = 302) using a random-effects model (I2 = 65%).Participation
The immediate effect of CIMT compared with the same dose of
upper limb therapy on participationwas examined by pooling data
after intervention from four comparisons with a PEDro score of
7.5 and 146 participants, using a random-effect model. Three
studies were unable to be included in the analysis because they
had no appropriate participation measure.14,24,41 CIMT did not
increase participation (SMD –0.02, 95% CI –0.34 to 0.31, I2 = 0%)
comparedwith the same dose of upper limb therapy (Figure 8). See
Figure 9 on the eAddenda for the detailed forest plot.[(Figure_4)TD$FIG]Study
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Figure 4. SMD (95% CI) of effect of constraint-induced movement therapy with no
intervention on upper limb participation immediately after intervention by pooling
data from eight trials (n = 215) using a random-effects model (I2 = 84%).
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Figure 8. SMD (95% CI) of effect of constraint-induced movement therapy with
same dose of upper limb therapy on upper limb participation immediately after
intervention by pooling data from four trials (n = 146) using a random-effects
model (I2 = 0%).
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Figure 6. SMD (95% CI) of effect of constraint-induced movement therapy with
same dose of upper limb therapy on upper limb activity immediately after
intervention by pooling data from ﬁve trials (n = 218) using a random-effect model
(I2 = 0%).
Chiu and Ada: Constraint-induced movement in cerebral palsy136Relation between the effect and duration of constraint-induced
movement therapy and age for activity and participation
There was no signiﬁcant relation between duration of CIMT
(total duration of CIMT) and effect of CIMT on activity (r = –0.25,
p = 0.46) or participation (r = –0.10, p = 0.81). Neither was there a
signiﬁcant relation between age and effect of CIMT on activity
(r = 0.37, p = 0.26) or participation (r = 0.58, p = 0.13).
Discussion
This systematic review found that CIMT had a beneﬁcial effect
compared with no/sham intervention for children with hemiplegic
cerebral palsy. Furthermore, the effect was beneﬁcial in terms of
both activity and participation, suggesting that the improved
upper limb activity carried over into what the children actually did
in real life with their upper limb. On the other hand, when CIMT
was compared with the same dose of upper limb therapy, there
was little effect on activity or participation. Neither duration of
CIMT nor age inﬂuenced the size of the effect of CIMT.
This review was based on randomised trials of reasonable to
good quality. Given that 8 was the likely maximum PEDro score
achievable, because it is not possible to blind the therapists or
participants during complex interventions such as CIMT, the mean
PEDro score of 5.8 for the papers included in this review suggested
that the ﬁndings were reasonably credible. Although CIMT waseffective, it was no more effective than the same dose of upper limb
therapy without restraint. This suggests that the mechanism of the
effect is the dose of practice undertaken, rather than the type of
practice (ie, CIMT). In the studies where CIMT was compared with
no/sham intervention, children in the CIMT group were restrained
for an average of 5 hours/day and they spent just over 50% of this
period engaged in supervised practice. In the studies where CIMT
was compared with the same dose of upper limb practice without
restraint, children in the CIMT group were restrained for an average
of 4 hours/day and they spent 100% of this period engaged in
supervised practice, sometimes carrying out extra unrestrained
practice.
The ﬁndings from this review are supported by the ﬁndings of
the only other systematic review to speciﬁcally examine CIMT
where a meta-analysis was performed.5 In this previous review,
when all studieswere pooled, CIMT provided amoderate beneﬁcial
effect of 0.55. When only the studies of CIMT against a non-
equivalent dose intervention were analysed, the estimated effect
size was 0.84, which was similar to our estimated effect size of
0.63 for activity and 1.21 for participation. On the other hand,
when only the studies of CIMT against an equivalent dose of
practice were analysed, the estimated effect size was 0.37, which is
larger than our estimated effect size of 0.05 for activity and –0.02
for participation. This may be because Chen et al5 included seven
studies in their analysis that were not considered dose equivalent
by our deﬁnition.12,13,26,36,40,43,44 Since the control groups in these
studies received less practice than the CIMT groups, this may
explain why the effect that Chen et al found was larger than in our
review. In a general review, Sazewski et al45 also came to the
conclusion that the mechanism of the effect was the dose of
practice undertaken, rather than the type of practice.
There were some limitations to this review. First, there were
some missing data, so not all the included studies are represented
in the ﬁnal pooled estimate, although this only amounts to 15% of
the total data. Second, although a large number of studies were
represented, most were of a small sample size. On average, there
were 33 participants per study included in the meta-analyses,
leaving the review vulnerable to small trial bias. Third, there were
high levels of statistical heterogeneity (I2 > 60%) in the analyses of
CIMT against no/sham intervention, and the source of this
heterogeneity was not obvious.
This review generates several implications for clinical practice
with children with hemiplegic cerebral palsy. CIMT is an effective
way to improve upper limb function at the activity level and this can
be expected to carry over into participation in real life. Given that
the same dose of practice without restraint is likely to result in the
same outcome, it seems that as long as large amounts of practice are
carried out, regardless ofwhether that iswith restraint (unimanual)
or without restraint (bimanual and unimanual), improvement will
occur. In the studies of CIMT against no/sham intervention, children
were supervised to practise using their upper limb for an average of
2.5 hours a day, with a further 2.5 hours of restraint forcing more
practice. Ultimately, the way in which practice is achieved may be
best chosen by a combination of the child and the parents, aswell as
the therapists. For example, it may be easier to ‘force’ practice over
long periods of time at home using CIMT than practising without
restraint under the supervision of parents.What is already known on this topic: Children with hemi-
plegia due to cerebral palsy may have impairments due to
damage to an immature brain, indirectly from compensatory
movements or from learned disuse. Such impairments may
result in limitations in activity requiring rehabilitation through-
out life.
What this study adds: Constraint-induced movement thera-
py is an effective way to improve upper limb function, but as
long as large amounts of practice are carried out, regardless of
whether that is achieved with or without restraint, this benefit
can be expected.
Research 137eAddenda: Figures 3, 5, 7 and 9; Appendices 1 and 2, can found
at: doi:10.1016/j.jphys.2016.05.013
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